NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced receipt of key guidance from the U.S. Food and Drug Administration ...

In today’s highly regulated environment for drug development and manufacturing ... with all requirements detailed in the FDA and EMA’s process validation guidelines. This article will discuss the ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating it into their process.

In conventional drug development, QA processes often ... For instance, automated testing platforms can rapidly process samples and generate detailed reports in real-time. This capability is ...

This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development. “AlphaFold was a watershed moment for AI in biology. It was ...

It’s a game-changer for the whole drug development process ... flexibility is essential for regulatory compliance and process auditability, especially when government regulations require detailed ...

New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.

$802 million = Cost to develop a new drug. 12-15 years = Time required from ... adverse events/toxicities. Obtain and process blood samples or other specialized samples. Facilitate referrals ...

It’s always a high-stakes gamble in the pharmaceutical industry to develop a new drug ... using AI to streamline the process is a “win-win” for all since the development phase will be ...

A major part of the drug development process is to weed out those compounds whose side effects overwhelm their therapeutic effects. This gets to the fundamental issue of efficacy vs effectiveness.